Evidence map›Paper›PMID 42911177›Full record

ArticleThe Journal of cell biology2026

Septins buffer actomyosin forces to protect the nucleus from genotoxic mechanical stress.

Franklin Mayca Pozo, Sarah M Butts, Andrew W Schaefer, Cristina Montagna, Elias T Spiliotis

Abstract read
In one paragraph

Article in The Journal of cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Franklin Mayca PozoDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0000-0003-0926-3336
Sarah M ButtsDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0009-0002-0106-2812
Andrew W SchaeferDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0000-0002-7214-3516
Cristina MontagnaDepartment of Radiology and Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.ORCID 0000-0003-2343-5851
Elias T SpiliotisDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0000-0003-1082-9763

Funding

Genomic Instability-Induced Senescence in Brain Aging and Alzheimer's DiseaseR01AG068908 · NIA · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI ELLERBY, LISA M, MONTAGNA, CRISTINA · 2025 to 2025
$432k
NIGMS NIH HHS GM136337NIH HHS P30CA072720-25NIH HHS R01 AG068908Owens Family FoundationUniversity of Virginia Comprehensive Cancer Center
6 · The paper itself

Abstract

Invasively migrating cells thread their nucleus through confined interstitial spaces. How cells protect the nucleus from intracellular forces is poorly understood. Here, we show that the septin cytoskeleton buffers the actomyosin forces that have been shown to power nuclear movement. Septin filaments comprising SEPT9, a septin amplified in breast cancer, align with perinuclear actomyosin cables, which exhibit higher tensile stress during 3D confined migration through narrower pores. SEPT9 depletion amplifies actin stress during confined migration and after myosin II hyperactivation in nonmigrating cells causing actin and nuclear envelope ruptures. Following confined migration, DNA breaks, nuclear blebs, micronuclei, and cell death increase in SEPT9-depleted cells, phenotypes rescued by the oncogenic SEPT9 isoform 1. Clinicogenomic data reveal that SEPT9 amplification associates with lower genomic alteration in aggressive breast tumors. We propose that septins are a mechanoprotective element of the cytoskeleton, and SEPT9 amplification enhances tumor cell survival by preventing nuclear damage.

Indexed as

ActomyosinBreast NeoplasmsCell NucleusDNA DamageSeptinsStress, MechanicalActinsAnimalsCell Line, TumorCell MovementFemaleHumansMyosin Type IIActinsActomyosinMyosin Type IISEPTIN9 protein, humanSeptins

Identifiers

PMID42911177
PMCPMC13689686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.